关注
Csaba Fehér
Csaba Fehér
Hospital Clinic de Barcelona; IRB Barcelona, IDIBAPS
在 clinic.cat 的电子邮件经过验证
标题
引用次数
引用次数
年份
Clinical characteristics and prognosis of infections caused by OXA-48 carbapenemase-producing Enterobacteriaceae in patients treated with ceftazidime-avibactam
C De la Calle, O Rodríguez, L Morata, F Marco, C Cardozo, ...
International journal of antimicrobial agents 53 (4), 520-524, 2019
822019
Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies
P Puerta-Alcalde, C Cardozo, M Suárez-Lledó, O Rodríguez-Núñez, ...
Clinical Microbiology and Infection 25 (4), 447-453, 2019
652019
Clinical characteristics and outcome of elderly patients with community-onset bacteremia
C Hernández, C Fehér, A Soriano, F Marco, M Almela, N Cobos-Trigueros, ...
Journal of Infection 70 (2), 135-143, 2015
592015
Effect of meropenem administration in extended infusion on the clinical outcome of febrile neutropenia: a retrospective observational study
C Fehér, M Rovira, A Soriano, J Esteve, JA Martínez, F Marco, E Carreras, ...
Journal of Antimicrobial Chemotherapy 69 (9), 2556-2562, 2014
582014
A Comparison of Current Guidelines of Five International Societies on Clostridium difficile Infection Management
C Fehér, J Mensa
Infectious Diseases and Therapy 5 (3), 207-230, 2016
562016
Evaluation of ceftazidime/avibactam for serious infections due to multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa
O Rodríguez-Núñez, M Ripa, L Morata, C de la Calle, C Cardozo, C Fehér, ...
Journal of global antimicrobial resistance 15, 136-139, 2018
482018
Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection
D Viasus, P Puerta-Alcalde, C Cardozo, M Suárez-Lledó, ...
Clinical Microbiology and Infection 26 (3), 345-350, 2020
382020
How Hyperprolactinemia Affects Sexual Function in Patients Under Antipsychotic Treatment
E Rubio-Abadal, N Del Cacho, G Saenz-Navarrete, B Arranz, RM Cambra, ...
Journal of Clinical Psychopharmacology 36 (5), 422-428, 2016
342016
The efficacy of fidaxomicin in the treatment of Clostridium difficile infection in a real-world clinical setting: a Spanish multi-centre retrospective cohort
C Fehér, EM Rubio, PM Amador, ADI Garcia-Campero, M Salavert, ...
European Journal of Clinical Microbiology & Infectious Diseases 36 (2), 295-303, 2017
302017
The intestinal microbiota as a reservoir and a therapeutic target to fight multi-drug-resistant bacteria: a narrative review of the literature
A Aira, C Fehér, E Rubio, A Soriano
Infectious diseases and therapy 8 (4), 469-482, 2019
292019
Community-onset bacteraemia of unknown origin: clinical characteristics, epidemiology and outcome
C Hernandez, N Cobos-Trigueros, C Feher, L Morata, C De La Calle, ...
European Journal of Clinical Microbiology and Infectious Diseases 33 (11), 1973, 2014
282014
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: a propensity score-adjusted …
M Ripa, O Rodríguez-Núñez, C Cardozo, A Naharro-Abellán, M Almela, ...
Journal of Antimicrobial Chemotherapy 72 (12), 3443-3452, 2017
272017
A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection
C Fehér, A Soriano, J Mensa
Infectious diseases and therapy 6 (1), 1, 2017
252017
rUTI resolution after FMT for clostridioides difficile infection: a case report
A Aira, E Rubio, A Vergara Gómez, C Fehér, C Casals-Pascual, ...
Infectious Diseases and Therapy 10 (2), 1065-1071, 2021
222021
Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response
L Leal, C Fehér, V Richart, B Torres, F García
Vaccines 8 (3), 442, 2020
142020
High rate of long-term clinical events after antiretroviral therapy resumption in HIV-positive patients exposed to antiretroviral therapy interruption
V Richart, I Fernández, E de Lazzari, L Berrocal, C Fehér, M Plana, L Leal, ...
AIDS 35 (15), 2463-2468, 2021
72021
Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients
C Fehér, L Leal, M Plana, N Climent, A Crespo Guardo, E Martínez, ...
Open Forum Infectious Diseases 6 (12), ofz485, 2019
72019
Multiple imputation approach for interval‐censored time to HIV RNA viral rebound within a mixed effects Cox model
Y Alarcón‐Soto, K Langohr, C Fehér, F García, G Gómez
Biometrical Journal 61 (2), 299-318, 2019
72019
Association of Transcriptomic Signatures of Inflammatory Response with Viral Control after Dendritic Cell-Based Therapeutic Vaccination in HIV-1 Infected Individuals
C Fehér, R Pastor-lbáñez, L Leal, M Plana, M Arnedo, HJ van den Ham, ...
Vaccines 9 (7), 799, 2021
42021
A Classifier to Predict Viral Control After Antiretroviral Treatment Interruption in Chronic HIV-1–Infected Patients
C Fehér, M Plana, AC Guardo, N Climent, L Leal, A Ugarte, I Fernández, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 83 (5), 479-485, 2020
32020
系统目前无法执行此操作,请稍后再试。
文章 1–20